For ER+ breast cancer, a low adiponectin concentration can amplify ER signaling to increase the proliferation of ER+ breast cancer cells, leading to the progression of breast tumors (40, 99, 100). The gene discussed is ADIPOQ; the disease is breast neoplasm.